Myelitis: Clinical Trials

5 withdrawn. 5 Phase 3, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	5	Withdrawn 5
Phase 2	1	Withdrawn 1

Follow Myelitis: new trials by email Literature Review of Myelitis trials Research Report on Myelitis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine bOPV and nOPV2 - Poliomyelitis	Phase 3	Withdrawn	Fidec Corporation		2020-12-01	2022-01-14
Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants Infanrix-IPV/Hib - Diphtheria, Acellular Pertussis	Phase 3	Withdrawn	GlaxoSmithKline		2017-12-01	2017-12-26
A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine IPV, f-IPV - Poliomyelitis	Phase 3	Withdrawn	Fidec Corporation		2017-07-01	2017-06-27
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya Quadrivalent Inactivated Influenza Vaccine (QIV), Inactivated Polio Vaccine, Double Dose QIV - Influenza, Human, HIV	Phase 2 / Phase 3	Withdrawn	Centers for Disease Control and Prevention		2014-04-01	2014-04-10
A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome L-carnitine and piracetam, Placebo - Postpoliomyelitis Syndrome	Phase 3	Withdrawn	Biolab Sanus Farmaceutica			2015-11-17

Narrower conditions

Poliomyelitis (4)  ·  Tetanus (2)  ·  Diphtheria (1)  ·  Haemophilus Infections (1)  ·  Influenza, Human (1)  ·  Malaria (1)  ·  Postpoliomyelitis Syndrome (1)

Broader conditions

Central Nervous System Diseases (5)  ·  Central Nervous System Infections (5)  ·  Enterovirus Infections (5)  ·  Infections (5)  ·  Nervous System Diseases (5)  ·  Neuroinflammatory Diseases (5)  ·  Neuromuscular Diseases (5)  ·  Picornaviridae Infections (5)  ·  RNA Virus Infections (5)  ·  Spinal Cord Diseases (5)  ·  Virus Diseases (5)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Clostridium Infections (2)

Interventions

Carnitine (1)  ·  Influenza Vaccines (1)  ·  Piracetam (1)  ·  Poliovirus Vaccine, Inactivated (1)  ·  Rabies Vaccines (1)  ·  diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (1)  ·  fluarix (1)

Sponsors

Fidec Corporation (2)  ·  Biolab Sanus Farmaceutica (1)  ·  Centers for Disease Control and Prevention (1)  ·  GlaxoSmithKline (1)

Countries

Brazil (1)  ·  Kenya (1)

Top investigators

Acary Souza Bulle Oliveira, MD, PhD (1)  ·  Joshua A Mott, PhD (1)  ·  Marc-Alain Widdowson, VetMB, MSc (1)  ·  Meredith L McMorrow, MD, MPH (1)  ·  Nancy Otieno, MS (1)  ·  Stella Gutierrez, MD (1)